Sentinel lymph-node biopsy in early-stage cervical cancer: the 4-year follow-up results of the senticol 2 trial

HIGHLIGHTS

• who: Guillaume Favre from the Department of Gynecology, University Hospital of Lausanne, Lausanne, Switzerland, Faculty of Biology and Medicine have published the research work: Sentinel Lymph-Node Biopsy in Early-Stage Cervical Cancer: The 4-Year Follow-Up Results of the Senticol 2 Trial, in the Journal: (JOURNAL) of 26/Oct/2020
• what: The aim of the Senticol 2 study was to compare the effect of sentinel-lymph-node biopsy (SLNB) to that of SLNB + pelvic lymphadenectomy (PLND), and to determine the postoperative lymphatic morbidity in the two groups. The authors report a secondary objective . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.